Q1 2021 Holdings
Filed 2021-05-17 | 56 holdings | $42.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $15.4M | 108,800 | 36.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $13.6M | 48,500 | 31.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $4.2M | 55,156 | 9.8% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $3.9M | 298,500 | 9.1% |
| Ascendis Pharma AS(ASND) | Sponsored ADR | 04351P101 | $1.8M | 13,800 | 4.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.5M | 59,514 | 3.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.1M | 21,500 | 2.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $793.0K | 14,000 | 1.9% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $36.2K | 393,000 | 0.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $25.1K | 387,784 | 0.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $20.7K | 43,800 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $20.1K | 207,000 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $20.0K | 886,534 | 0.0% |
| PTC Therapuetics COM(PTCT) | COM | 69366J200 | $19.3K | 408,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $18.5K | 133,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $18.3K | 85,322 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $15.0K | 333,781 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $14.8K | 288,600 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $12.1K | 176,400 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $11.5K | 67,400 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $10.7K | 43,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $9.5K | 282,034 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $8.2K | 60,500 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $7.7K | 81,541 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $6.3K | 78,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $6.3K | 16,300 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.5K | 214,533 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $4.5K | 100,000 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $4.4K | 26,600 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.9K | 152,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $3.2K | 139,331 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $2.7K | 79,456 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $2.7K | 22,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $2.3K | 31,500 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $2.3K | 20,100 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $1.9K | 19,500 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $1.8K | 58,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $1.8K | 15,700 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $1.7K | 35,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $1.6K | 21,500 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM | 040047607 | $1.5K | 21,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.5K | 93,886 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $1.4K | 34,633 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $1.4K | 10,700 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $1.3K | 67,000 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.3K | 53,000 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $1.1K | 33,600 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | CM | 03753U106 | $1.0K | 23,400 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $935 | 94,600 | 0.0% |
| Global Blood Therapeutics | COM | 37890U108 | $888 | 21,800 | 0.0% |